This week, the overall grades of 7 Life Sciences Tools & Services stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
This is a rough week for Thermo Fisher Scientific Inc. (TMO). The company’s rating falls to D from the previous week’s C. Thermo Fisher Scientific Inc. manufactures and sells products to assist in the pharmaceutical, academic, and other related research and industrial markets. For more information, get Portfolio Grader’s complete analysis of TMO stock.
ICON Plc (ICLR) earns a D this week, moving down from last week’s grade of C. ICON Plc provides contract clinical research services to the global pharmaceutical industry. For more information, get Portfolio Grader’s complete analysis of ICLR stock.
INC Research Holdings, Inc. Class A’s (INCR) rating weakens this week, dropping to a D versus last week’s C. The company also gets F’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of INCR stock.
Agilent Technologies, Inc. (A) declines this week from a C to a D. Agilent Technologies, Inc. serves the communications, electronics, life sciences, and chemical analysis industries by designing and producing bio-analytical and electronic measurement solutions. For more information, get Portfolio Grader’s complete analysis of A stock.
VWR Corp. (VWR) gets weaker ratings this week as last week’s C drops to a D. For more information, get Portfolio Grader’s complete analysis of VWR stock.
This week, Accelerate Diagnostics, Inc. (AXDX) drops from a B to a D rating. Accelerate Diagnostics, Inc. develops diagnostic systems for bacterial infections. The company also gets F’s in sales growth and return on equity. For more information, get Portfolio Grader’s complete analysis of AXDX stock.
This week, Bruker Corporation’s (BRKR) rating worsens to a D from the company’s C rating a week ago. Bruker Corporation designs, manufactures, markets and serves proprietary life science and materials research systems based on its core technology platforms, including X-ray technologies, magnetic resonance technologies, mass spectrometry technologies, optical emission spectroscopy and infrared and Raman molecular spectroscopy technologies. For more information, get Portfolio Grader’s complete analysis of BRKR stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.